Particle.news
Download on the App Store

Tatiana Schlossberg Reveals Terminal Leukemia, Says Doctor May Keep Her Alive ‘A Year, Maybe’

In a New Yorker essay, she links her limited options to federal health decisions she says are curbing cancer research.

Overview

  • Schlossberg, 35, disclosed she was diagnosed with acute myeloid leukemia with the rare Inversion 3 mutation shortly after giving birth in May 2024.
  • Her treatments have included multiple rounds of chemotherapy, two stem‑cell transplants—first from her sister, then from an unrelated donor—and participation in CAR‑T and other clinical trials.
  • She wrote that an Epstein–Barr virus complication in September damaged her kidneys and forced her to relearn how to walk.
  • Her oncologist told her during a recent trial that he could keep her alive for about a year, prompting her to focus on time with her 3‑year‑old son and 1‑year‑old daughter.
  • She criticized Health and Human Services Secretary Robert F. Kennedy Jr. for cuts to mRNA and NIH research funding and described uncertainty at Columbia’s medical center before federal funding was later restored.